ADVERSE DRUG EVENT
Clinical trials for ADVERSE DRUG EVENT explained in plain language.
Never miss a new study
Get alerted when new ADVERSE DRUG EVENT trials appear
Sign up with your email to follow new studies for ADVERSE DRUG EVENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart surgery bleeding study seeks best drug dose
Disease control Recruiting nowThis study looks at different doses of tranexamic acid, a medicine used to prevent bleeding during heart surgery. The goal is to find out which dose works best to stop bleeding and reduce the need for blood transfusions. About 150 adults having planned heart surgery with a heart-…
Matched conditions: ADVERSE DRUG EVENT
Phase: NA • Sponsor: University of Ioannina • Aim: Disease control
Last updated May 16, 2026 22:31 UTC
-
Sleep hormone may shield kidneys from antibiotic damage
Prevention Recruiting nowThis study tests whether melatonin, a natural sleep hormone, can prevent kidney injury caused by strong antibiotics in hospitalized patients. Researchers will give melatonin to 300 adults aged 18-75 who are starting vancomycin therapy. The goal is to see if melatonin reduces the …
Matched conditions: ADVERSE DRUG EVENT
Phase: PHASE3 • Sponsor: Rutgers, The State University of New Jersey • Aim: Prevention
Last updated May 15, 2026 11:57 UTC
-
New sedative could improve recovery for ventilator patients in ICU
Symptom relief Recruiting nowThis study looks at whether a drug called remazolam besylate is as good as or better than another sedative (dexmedetomidine) for keeping critically ill patients calm and comfortable while they are on a breathing machine after non-cardiac surgery. About 306 adults aged 18-64 who n…
Matched conditions: ADVERSE DRUG EVENT
Phase: PHASE4 • Sponsor: Beijing Shijitan Hospital, Capital Medical University • Aim: Symptom relief
Last updated May 08, 2026 12:01 UTC
-
Gene study aims to predict chemo side effects in kids with leukemia
Knowledge-focused Recruiting nowThis study observes 500 Indian children with acute lymphoblastic leukemia to see how their genes influence treatment side effects and response to steroids. Researchers will track toxicities and treatment outcomes over five years. No new drug is tested; the goal is to better under…
Matched conditions: ADVERSE DRUG EVENT
Sponsor: University of Geneva, Switzerland • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC